Specifically, WHI found there was a 54 percent increased risk of death after a colorectal cancer diagnosis when female patients were randomized to combined hormone therapy compared to placebo trials. Although a few number of colorectal cancers resulted from the combined-therapy group, the group was at higher risk of mortality.
Read the abstract on menopausal hormone therapy and CRC.
Read other coverage about colorectal cancer:
– Studies Show Mailed and Electronic Reminders Increase Colorectal Cancer Screening Rates
– Study Suggests Hormone Therapy Could Increase Risk of CRC by Up To 40%
– 10 Recent Studies and Breakthroughs Impacting Gastroenterology/Endoscopy
